FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 132 filers reported holding FLEXION THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $36,711,000 | -24.2% | 4,101,735 | -2.2% | 0.95% | -35.5% |
Q4 2020 | $48,423,000 | -11.8% | 4,196,100 | -20.4% | 1.47% | -25.3% |
Q3 2020 | $54,907,000 | -19.6% | 5,274,439 | +1.5% | 1.97% | -35.0% |
Q2 2020 | $68,321,000 | +104.8% | 5,195,550 | +22.6% | 3.03% | +41.4% |
Q1 2020 | $33,365,000 | -67.3% | 4,239,469 | -14.1% | 2.15% | -40.8% |
Q4 2019 | $102,111,000 | +42.8% | 4,932,875 | -5.4% | 3.62% | +26.1% |
Q3 2019 | $71,483,000 | +19.8% | 5,215,810 | +7.5% | 2.87% | +26.6% |
Q2 2019 | $59,685,000 | +16.4% | 4,852,460 | +18.1% | 2.27% | +11.8% |
Q1 2019 | $51,289,000 | +45.5% | 4,109,720 | +32.0% | 2.03% | +27.1% |
Q4 2018 | $35,244,000 | -34.6% | 3,113,390 | +8.1% | 1.60% | -8.1% |
Q3 2018 | $53,907,000 | -21.4% | 2,881,200 | +8.6% | 1.74% | -32.1% |
Q2 2018 | $68,600,000 | +14.7% | 2,653,775 | -0.6% | 2.56% | +2.7% |
Q1 2018 | $59,832,000 | -11.0% | 2,669,900 | -0.5% | 2.49% | -12.8% |
Q4 2017 | $67,220,000 | +135.3% | 2,684,500 | +127.2% | 2.86% | +132.9% |
Q3 2017 | $28,564,000 | +167.7% | 1,181,325 | +123.8% | 1.23% | +183.6% |
Q2 2017 | $10,672,000 | – | 527,800 | – | 0.43% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|